Ensign Peak Advisors’s Agios Pharmaceuticals AGIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $831K | Sell |
24,970
-6,950
| -22% | -$231K | ﹤0.01% | 1353 |
|
|
2025
Q1 | $935K | Hold |
31,920
| – | – | ﹤0.01% | 1293 |
|
|
2024
Q4 | $1.05M | Hold |
31,920
| – | – | ﹤0.01% | 1294 |
|
|
2024
Q3 | $1.42M | Hold |
31,920
| – | – | ﹤0.01% | 1120 |
|
|
2024
Q2 | $1.38M | Hold |
31,920
| – | – | ﹤0.01% | 1082 |
|
|
2024
Q1 | $933K | Sell |
31,920
-1,610
| -5% | -$47.1K | ﹤0.01% | 1376 |
|
|
2023
Q4 | $747K | Hold |
33,530
| – | – | ﹤0.01% | 1535 |
|
|
2023
Q3 | $830K | Hold |
33,530
| – | – | ﹤0.01% | 1340 |
|
|
2023
Q2 | $950K | Hold |
33,530
| – | – | ﹤0.01% | 1305 |
|
|
2023
Q1 | $770K | Hold |
33,530
| – | – | ﹤0.01% | 1444 |
|
|
2022
Q4 | $942K | Buy |
33,530
+21,100
| +170% | +$592K | ﹤0.01% | 1209 |
|
|
2022
Q3 | $352K | Buy |
12,430
+250
| +2% | +$7.08K | ﹤0.01% | 1633 |
|
|
2022
Q2 | $270K | Hold |
12,180
| – | – | ﹤0.01% | 1710 |
|
|
2022
Q1 | $355K | Hold |
12,180
| – | – | ﹤0.01% | 1692 |
|
|
2021
Q4 | $400K | Buy |
+12,180
| New | +$400K | ﹤0.01% | 1701 |
|